NIH to study immune system supplement in HIV-infected women.
D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D009316:National Institutes of Health (U.S.); D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy*; D014481:United States
C084715:HIV hyperimmune globulin; D016756:Immunoglobulins, Intravenous